Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Automated Breast Ultrasound Systems Market Set to Register a CAGR of 14.20% and Reach USD 10.11 Billion by 2031 – Growth Plus Reports

Published

on

<!– Name:DistributionId Value:8800438 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:2790 –> <!– Name:CustomerId Value:1222559 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:cbf56c15-31f1-4902-a860-6965417e842c –>

Newark, New Castle, USA, April 03, 2023 (GLOBE NEWSWIRE) — According to the latest Growth Plus Reports assessment, the automated breast ultrasound systems market is estimated to reach US$ 10.11 billion by 2031, with a CAGR of 14.20%. The report analyzes vital growth strategies, factors, prospects, competition, industry trends, market dynamics, data and forecasts, and ideal investment regions.

Key Takeaways:

  • The increased prevalence of breast cancer will drive the market’s revenue growth.
  • North America will register the fastest-revenue growth in the automated breast ultrasound systems market.
  • The need for advanced imaging will fuel the growth of the market. 

Request a Free Sample of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/automated-breast-ultrasound-systems-market/8482

Automated Breast Ultrasound Systems Market Scope

Report Attribute Details
Market size value in 2022 US$ 3.06 billion
Revenue forecast in 2031 US$ 10.11 billion
Growth Rate CAGR of 14.2% from 2023 to 2031
Base year for estimation 2022
Forecast Period 2023-2031
Historical Year 2021
Segments covered Product, End User, and Region
Regional scope North America, Europe, Asia Pacific, and the Rest of the World (ROW)

Market Drivers
The advances in automated breast ultrasound (ABUS) are the major factors driving the revenue growth of the global automated breast ultrasound systems market. Furthermore, the increasing demand for more advanced cancer imaging, the rapidly increasing number of breast cancer patients, and the launch of novel products contribute to the market’s revenue growth rate. 

Market Segmentation
Growth Plus Reports has analyzed the global automated breast ultrasound systems market from four perspectives: Product, End User, and Region.

Product Segmentation: On the basis of product, the automated breast ultrasound systems market is segmented into automated breast ultrasound systems (ABUS) and breast volume scanners (ABVS). The automated breast ultrasound systems (ABUS) segment accounts for the largest revenue share because of technological advancements and user-friendly device features.

End-User Segmentation: Based on the end-user, the global automated breast ultrasound systems market is segmented into hospitals, diagnostics imaging laboratories, and clinics. The hospital segment dominates the market because of the increased prevalence of breast cancer, the introduction of technologically advanced products, and growing awareness about the condition and its treatment.
  
Regional Growth Dynamics
Based on the region, the global automated breast ultrasound systems market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to dominate the automated breast ultrasound systems market with the largest revenue share. The dominance of North America is attributed to the increasing prevalence of cancer, the presence of key players, advanced healthcare infrastructure, and favorable reimbursement policies.

Request for Customization – https://www.growthplusreports.com/inquiry/customization/automated-breast-ultrasound-systems-market/8482

Competitive Landscape
The prominent players in the global automated breast ultrasound systems market are:

  • General Electric Company
  • Hitachi, Ltd.
  • Koninklijke Philips N.V.
  • Siemens Healthineers AG
  • Telemed Medical Systems
  • Canon Medical Systems Corporation
  • Fukuda Denshi
  • Nova Medical Imaging Technology Co. Ltd
  • Hologic, Inc.
  • SuperSonic Imagine
  • QView Medical Inc.

The automated breast ultrasound systems market is extremely competitive, with several players involved. Market giants use mergers, collaborations, and acquisitions to increase their market share and launch new drugs and products.

Recent developments:

  • CAD, Inc., iCAD, Inc., a global medical technology company that provides advanced cancer detection and therapy solutions, and Ferrum Health, a pioneer in healthcare enterprise AI solutions, have agreed to make iCAD’s breast AI solutions available on Ferrum Health’s platform beginning in November 2022.
  • Siemens Healthineers and HeartVista partnered in November 2022 to completely integrate HeartVista’s artificial intelligence algorithms for chest imaging into Siemens’ MRI equipment. The two firms collaborated to develop an automated clinical imaging procedure that uses MRI sequences (techniques).
  • Accuray Incorporated announced in October 2022 that, in collaboration with C-RAD AB, it would provide a crucial new alternative for enhancing the care of women with breast cancer. In December 2021, Health Canada will approve its first domestically made 3D printed implant Specific 3D mandibular plate.

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
  3. PREMIUM INSIGHTS
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2022) 
    3. Regulatory Landscape
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
  5. GLOBAL AUTOMATED BREAST ULTRASOUND SYSTEMS MARKET – ANALYSIS & FORECAST, BY PRODUCT
    1. Automated Breast Ultrasound System 
    2. Automated Breast Volume Scanner
  6. GLOBAL AUTOMATED BREAST ULTRASOUND SYSTEMS MARKET – ANALYSIS & FORECAST, BY END USER
    1. Hospitals
    2. Diagnostics Imaging Laboratories
    3. Others

AUTOMATED BREAST ULTRASOUND SYSTEMS MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8482

VALUE PROPOSITIONS RELATED TO THE REPORT:

  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

CUSTOMIZATION OPTIONS:

  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse related reports:

Leadless Cardiac Pacemaker Market by Type (Micra Transcatheter Pacing System, Aveir VR Leadless Pacemaker), by Condition (Atrial Fibrillation, Sinus Node Dysfunction, Atrioventricular Block) – Global Outlook & Forecast 2022-2030

Digital Experience Platform Market by Component (Services and Platform), by Deployment Type (Cloud-Based and On-Premises), by Application (Business to Business and Business to Customer), and by End User (IT & Telecom, Healthcare, Media and Entertainment, Education, BFSI, and Retail) – Global Outlook & Forecast 2022-2030

Biliary Stents Market by Type (Metal Stents and Polymer Stents), by Application (Gallstones, Bilio-Pancreatic Leakages, Malignant Obstruction, and Benign Biliary Structures) and End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers) – Global Outlook & Forecast 2022-2030

Dehydration Monitoring Systems Market by Product (Mobile Devices, Wearable Devices), by Application (Disease Diagnosis, Drug Abuse Detection, Athletic Performance Optimization) – Global Outlook & Forecast 2022-2030

Hearing Aids Devices Market by Product (Hearing Devices and Hearing Implants), by Patient Type (Adults and Pediatrics), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) – Global Outlook & Forecast 2022-2030

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

JupiterOne and watchTowr announce partnership to protect business critical assets with broad exposure management capabilities

Published

on

jupiterone-and-watchtowr-announce-partnership-to-protect-business-critical-assets-with-broad-exposure-management-capabilities

SINGAPORE, May 2, 2024 /PRNewswire/ — watchTowr, a leader in external attack surface management (EASM) technology and fuelled by watchTowr Labs, a renowned vulnerability R&D capability, has formed a strategic partnership with JupiterOne. JupiterOne is a leader in cyber asset attack surface management (CAASM) technology. This collaboration enables customers to rapidly prioritize emerging threats within their constantly changing environments, focusing on fixing the most critical risks impacting their business, which enables an end-to-end continuous threat exposure management process (CTEM).

Over 28,000 CVE records were published in 2023; a figure that is expected to increase as attackers shorten the time from known vulnerability to exploit, reducing it from weeks to days. JupiterOne and watchTowr’s integrated solution empowers enterprises to discover their most critical and exploitable vulnerabilities, prioritize them with asset context based on business impact and receive an actionable remediation plan to improve security posture.
This partnership enables a complete continuous threat exposure management program, addressing the full spectrum of cyber risk management. The fully integrated solution provides continuous monitoring and assessment of both internal and external digital assets, allowing for prioritization and effective threat mitigation for a business’s most critical assets. “Our partnership with watchTowr is a game-changer” said Forte. “Combining our data aggregation with real-time asset discovery and automated security testing allows us to offer a unique, all-encompassing approach to exposure management.”
Benjamin Harris, CEO, watchTowr, said, “While the number of reported vulnerabilities continues to rise, the vulnerabilities that matter – in mission-critical, key systems – have exploded at an alarming rate. This reality, combined with the significant shift in speed by attackers to weaponize vulnerabilities – the ability to validate exploitability and prioritise actions based on real business risk has never been more vital. We’re excited to join forces with JupiterOne to give security teams around the globe this much-needed end-to-end capability.”
About JupiterOne:
JupiterOne is a cybersecurity startup delivering powerful software solutions to companies across all industries, providing deep insights to cyber assets and the relationships between, empowering security professionals to have true knowledge and ownership of their attack surfaces.
About watchTowr: 
watchTowr is a global cybersecurity technology company, built by former adversaries.
watchTowr’s world-class External Attack Surface Management and Continuous Automated Red Teaming technology is informed by years of experience compromising some of the world’s most targeted organisations and utilised by Fortune 500, financial services and critical infrastructure providers every day.
Photo – https://mma.prnewswire.com/media/2401497/watchTowr_JupiterOne.jpg

View original content:https://www.prnewswire.co.uk/news-releases/jupiterone-and-watchtowr-announce-partnership-to-protect-business-critical-assets-with-broad-exposure-management-capabilities-302132392.html

Continue Reading

Artificial Intelligence

Clarivate Declares Dividend on Mandatory Convertible Preferred Shares

Published

on

clarivate-declares-dividend-on-mandatory-convertible-preferred-shares

LONDON, May 1, 2024 /PRNewswire/ — Clarivate Plc (NYSE: CLVT; CLVT PR A) (“Clarivate”), a leading global provider of transformative intelligence, today announced that its board of directors declared a quarterly dividend of $1.3125 per share on its 5.25% Series A Mandatory Convertible Preferred Shares (the “Preferred Shares”), payable in cash on June 3, 2024 to shareholders of record at the close of business on May 15, 2024.

On the mandatory conversion date, which is scheduled to occur on June 3, 2024, each Preferred Share will automatically and mandatorily convert into a number of ordinary shares of Clarivate (and cash in lieu of any fractional ordinary shares) based on the average volume weighted average price (“VWAP”) of Clarivate’s ordinary shares over a 30-trading day period that begins on, and includes, April 18, 2024 and is scheduled to end on, and include, May 30, 2024 (the “valuation period”). If such VWAP is (i) greater than $31.20, then the mandatory conversion rate will be 3.2052 ordinary shares of Clarivate per Preferred Share, (ii) less than or equal to $31.20 but equal to or greater than $26.00, then the mandatory conversion rate will be a number of ordinary shares of Clarivate per Preferred Share equal to $100.00 divided by such VWAP and (iii) less than $26.00, then the mandatory conversion rate will be 3.8462 ordinary shares of Clarivate per Preferred Share. The mandatory conversion rate will be announced following the end of the valuation period. The above description of the terms of the Preferred Shares is not complete and is subject to, and qualified in its entirety by reference to, the “Statement of Rights” for the Preferred Shares, which is filed as Exhibit 3.2 to Clarivate’s annual report on Form 10-K for the fiscal year ended December 31, 2023.
Cautionary Note Regarding Forward-Looking Statements
This communication contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. These statements, which express management’s current views concerning future business, events, trends, contingencies, financial performance, or financial condition, appear at various places in this communication and may use words like “aim,” “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecast,” “future,” “goal,” “intend,” “likely,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “see,” “seek,” “should,” “strategy,” “strive,” “target,” “will,” and “would” and similar expressions, and variations or negatives of these words. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on management’s current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. These forward-looking statements involve a number of risks and uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include those factors discussed under the caption “Risk Factors” in our annual report on Form 10-K, along with our other filings with the U.S. Securities and Exchange Commission (“SEC”). However, those factors should not be considered to be a complete statement of all potential risks and uncertainties. Additional risks and uncertainties not known to us or that we currently deem immaterial may also adversely affect our business operations. Forward-looking statements are based only on information currently available to our management and speak only as of the date of this communication. We do not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, except as otherwise required by securities and other applicable laws. Please consult our public filings with the SEC or on our website at www.clarivate.com.
About Clarivate
Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com.
Logo – https://mma.prnewswire.com/media/1159266/Clarivate_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/clarivate-declares-dividend-on-mandatory-convertible-preferred-shares-302133633.html

Continue Reading

Artificial Intelligence

CGTN: 3rd CMG Forum in Beijing discusses AI development

Published

on

cgtn:-3rd-cmg-forum-in-beijing-discusses-ai-development

BEIJING, May 1, 2024 /PRNewswire/ — Focusing on the development of AI, the third CMG Forum was held on Monday in Beijing.

Li Shulei, a member of the Political Bureau of the Communist Party of China (CPC) Central Committee and the head of the Publicity Department of the CPC Central Committee, attended the opening of the event and delivered a speech.
Guests at the forum stressed the role of media in promoting the innovative application of AI as well as its governance.
Efforts should also be made to boost the development of AI in creating positive, healthy, diverse and high-quality content, so that AI can become a force for good and benefit mankind, they agreed.
They also called on media to accelerate intelligent transformation and help bridge international exchanges and cooperation on the governance of AI to facilitate its healthy, orderly and safe development.
Hosted by China Media Group (CMG), the forum attracted more than 200 participants from international organizations, media, think tanks and multinational companies.
“Innovation and breakthroughs in science and technology not only guide the development and progress of human civilization, but also bring uncertainty to the changing world,” said Shen Haixiong, vice minister of the Publicity Department of the CPC Central Committee and president of CMG. He called for efforts to jointly create valuable and responsible artificial intelligence.
AI technology is affecting every aspect of our lives. Thomas Bach, president of the International Olympic Committee (IOC), stated in a video speech that CMG has always been a partner of the IOC, bringing the charm of the Olympic Games to hundreds of millions of Chinese viewers. He said the IOC invites CMG to work together for the creation of a future with the application of AI in Olympic sports.
“From ancient inventions such as silk, printing and the compass to modern technological advances such as robotics, telecommunications and green technology, China has always been committed to innovation and creation,” said Daren Tang, director general of the World Intellectual Property Organization (WIPO). He said WIPO pays close attention to ensuring a balance between the opportunities and risks of artificial intelligence and is committed to strengthening cooperation to ensure that artificial intelligence is properly used.
https://news.cgtn.com/news/2024-04-30/3rd-CMG-Forum-in-Beijing-discusses-AI-development-1tdDcXvCexG/p.html

View original content:https://www.prnewswire.co.uk/news-releases/cgtn-3rd-cmg-forum-in-beijing-discusses-ai-development-302133410.html

Continue Reading

Trending